Grab a jacket as temps start out in the upper 40s to mid 50s across the Bay Area with a few showers possible along the nature coast. More clouds arrive this afternoon with a stray shower possible.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Transcatheter tricuspid valve replacement using the ...

Edwards Lifesciences has received US Food and Drug Administration (FDA) approval for its Evoque tricuspid valve replacement system, which becomes the first transcatheter therapy to be approved in the ...

CHICAGO -- Discussing their predictions on where transcatheter technologies in the tricuspid space are going, some experts said they favored the odds of replacement over repair when devices are ready ...

San Francisco — In the first randomized controlled trial using the TriClip Transcatheter Tricuspid Valve Repair system (Abbott) for transcatheter edge-to-edge repair (TEER) of the tricuspid valve in ...

NEW YORK, NY—High-grade atrioventricular (AV) block occurs within 1 month for roughly one in seven patients who undergo transcatheter tricuspid valve replacement (TTVR), according to new results from ...

Edwards Lifesciences has claimed the FDA’s first approval of a transcatheter replacement implant for a leaky tricuspid heart valve, three months after garnering a green light in Europe. The Evoque, ...

The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for ...

The US Centers for Medicare & Medicaid Services (CMS) has finalized its national coverage determination (NCD) for transcatheter tricuspid valve replacement (TTVR) when used to treat patients with ...

Severe tricuspid regurgitation is associated with disabling symptoms and an increased risk of death. Transcatheter tricuspid-valve replacement may improve outcomes. New research findings are ...